{"id":"W3016352045","doi":"10.3747/co.27.5121","title":"Immune Checkpoint Inhibitors in Genitourinary Malignancies","year":2020,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Oncology; Renal cell carcinoma; Prostate cancer; Kidney cancer; Genitourinary system; Durvalumab; Clinical trial; Disease; Immunotherapy; Metastatic Urothelial Carcinoma; Immune checkpoint; Cancer; Internal medicine; Nivolumab; Bladder cancer; Urothelial carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003562554,0.0006502495,0.001024193,0.001640371,0.000207979,0.0006546395,0.0005614054,0.0006886491,0.004699307],"category_scores_gemma":[0.0005515994,0.0001675439,0.0006683386,0.001295837,0.0001968392,0.0006979653,0.0004296875,0.001503227,0.001387846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004711483,"about_ca_system_score_gemma":0.0008577764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001052969,"about_ca_topic_score_gemma":0.002090748,"domain_scores_codex":[0.9998609,0.00002735767,0.00002202817,0.00002095578,0.00005358293,0.00001513727],"domain_scores_gemma":[0.9998202,0.00009310002,0.00003235574,0.00000403741,0.00003752233,0.00001291424],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008424358,0.00006035817,0.00009912981,0.02565272,0.000121915,0.0001089146,0.00004157823,0.0003344502,0.0009535908,0.002060617,0.02648683,0.9439957],"study_design_scores_gemma":[0.00003421525,0.0001190555,0.0007540698,0.01042314,0.0002125084,0.0009493086,0.00003407312,0.00008546829,0.0002999651,0.001304219,0.9857721,0.00001188667],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009889039,0.9986783,0.00004415454,0.0001326103,0.0001393192,0.000004972182,0.00001568374,0.000005733943,0.0008803265],"genre_scores_gemma":[0.0006443073,0.9984597,0.0001014117,0.0001683531,0.00008856683,0.000006182303,0.00002781154,0.000001097715,0.0005024807],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004699307,"threshold_uncertainty_score":0.01572078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1520225778227039,"score_gpt":0.4336361108550326,"score_spread":0.2816135330323287,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}